Cancer Center evaluates the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage III-IV Soft Tissue Sarcoma of the Trunk and Extremities
M.D. Anderson Cancer Center is conducting the clinical trial Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage III-IV Soft Tissue Sarcoma of the Trunk and Extremities.
This clinical trial aims to learn how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage III-IV soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.
Actual study start date is December 28, 2020. The researchers expect to complete the study by December 31, 2024.
One primary outcome measure is Mean area under the curve of the Fear of Cancer Recurrence Inventory - Short Form, Will be estimated along with a 95% confidence interval within each study group.
Among the inclusion criteria are:
- >= 18 years old
- Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8 weeks of study enrollment
- Willingness to complete surveys x 2 years
- Pregnant women will be included in this clinical trial
The location of the study is as follows (further details can be found here https://ichgcp.net/clinical-trials-registry/NCT04751409) Houston, United States.
